Gastric mucosal defense and cytoprotection

Best Practice and Research: Clinical Gastroenterology

Volumn 24, Issue 2, 2010, Pages 99-108

  Tulassay, Zsolt ^a,b   Herszényi, László ^a,b  

^a SEMMELWEIS UNIVERSITY OF MEDICINE   (Hungary)

^b INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

Author keywords

Cytoprotection; Gastric mucosa; Growth factors; Microcirculation; Prostaglandins

Indexed keywords

ALUMINUM DERIVATIVE; ANTACID AGENT; ANTIULCER AGENT; BICARBONATE; BOMBESIN; CHOLECYSTOKININ; CORTICOTROPIN RELEASING FACTOR; CYTOKINE; EPIDERMAL GROWTH FACTOR; GASTRIN; GHRELIN; GROWTH FACTOR; HYDROGEN SULFIDE; LEPTIN; NEUROKININ A; NITRIC OXIDE; PEPTIDE YY; PHOSPHOLIPID; POLYAMINE; PROSTAGLANDIN; PROSTAGLANDIN E2; PROTEINASE; PROTEINASE ACTIVATED RECEPTOR; PROTIRELIN; REBAMIPIDE; SOMATOSTATIN; SUCRALFATE; THIOL DERIVATIVE; TRANSFORMING GROWTH FACTOR ALPHA;

ARTICLE; CELL PROTECTION; CELL RENEWAL; DEFENSE MECHANISM; DRUG INDUCED DISEASE; DRUG MECHANISM; HORMONAL REGULATION; HORMONE ACTION; HUMAN; INFLAMMATION; PROTEIN FUNCTION; SENSORY NERVE; STOMACH BLOOD FLOW; STOMACH EPITHELIUM; STOMACH INJURY; STOMACH JUICE; STOMACH MUCOSA; STOMACH MUCUS; STOMACH PROTECTION; ULCER HEALING;

ANTI-ULCER AGENTS; CYTOPROTECTION; DRUG THERAPY; GASTRIC MUCOSA; GASTRITIS; HUMANS; HYDROGEN-ION CONCENTRATION; INFLAMMATION MEDIATORS; STOMACH ULCER; WOUND HEALING;

EID: 77749341364     PISSN: 15216918     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bpg.2010.02.006     Document Type: Article

References (98)

1. Wallace J.L. Prostaglandins, NSAIDs, and gastric mucosal protection: why doesn't the stomach digest itself?. Physiol Rev 88 (2008) 1547-1565
2. Vane J.R. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nat New Biol 232 (1971) 232-235
3. Wallace J.L., and Granger D.N. The cellular and molecular basis of gastric mucosal defense. FASEB J 10 (1996) 731-740
4. Robert A., Nezamis J.E., Lancaster C., et al. Cytoprotection by prostaglandins in rats. Prevention of gastric necrosis produced by alcohol, HCL, hypertonic NaCl and thermal injury. Gastroenterology 77 (1978) 433-443
5. Robert A., Nezamis J.E., Lancaster C., et al. Mild irritants prevent gastric necrosis through adaptive 'cytoprotection' mediated prostaglandins. Am J Physiol 245 (1983) G113-G121
6. Zhu A., and Kaunitz J. Gastroduodenal mucosal defense. Curr Gastroenterol Rep 10 (2008) 548-554
7. Laine L., Takeuchi K., and Tarnawski A. Gastric mucosal defense and cytoprotection: bench to bedside. Gastroenterology 135 (2008) 41-60
8. Othman M., Aguero R., and Lin H.C. Alterations in intestinal microbial flora and human disease. Curr Opin Gastroenterol 24 (2008) 11-16
9. Rana S.V., and Bhardwaj S.B. Small intestinal bacterial overgrowth. Scand J Gastroenterol 43 (2008) 1030-1037
10. Martinsen T.C., Bergh K., and Waldum H.L. Gastric juice: a barrier against infectious diseases. Basic Clin Pharmacol Toxicol 96 (2005) 94-102
11. Tennant S.M., Hartland E.L., Phumoonna T., et al. Influence of gastric acid on susceptibility to infection with ingested bacterial pathogens. Infect Immun 76 (2008) 639-645
12. Liévin-Le Moal V., and Servin A.L. The front line of enteric host defense against unwelcome intrusion of harmful microorganisms: mucins, antimicrobial peptides, and microbiots. Clin Microbiol Rev 19 (2006) 315-337
13. Meyer-Hoffert U., Hornef M.W., Henriques-Normark B., et al. Secreted enteric antimicrobial activity localises to the mucus surface layer. Gut 57 (2008) 764-771
14. Allen A., and Flemström G. Gastroduodenal mucus bicarbonate barrier: protection against acid and pepsin. Am J Physiol Cell Physiol 288 (2005) C1-C19
15. Lichtenberger L.M. Gastroduodenal mucosal defense. Curr Opin Gastroenterol 15 (1999) 463-472
16. Darling R.L., Romero J.J., Dial E.J., et al. The effects of aspirin on gastric mucosal integrity, surface hydrophobic, and prostaglandin metabolism in cyclooxygenase knockout mice. Gastroenterology 127 (2004) 94-104
17. Ham M., and Kaunitz J.D. Gastroduodenal mucosal defense. Curr Opin Gastroenterol 24 (2008) 665-673
18. Kang H.M., Kim N., Park Y.S., et al. Effects of Helicobacter pylori infection on gastric mucin expression. J Clin Gastroenterol 42 (2008) 29-35
19. Reeves E.P., Ali T., Leonard P., et al. Helicobacter pylori lipopolisaccharides interacts with TFF1 in a pH-dependent manner. Gastroenterology 35 (2008) 2043-2054
20. Schmitz J.M., Durham C.G., Ho S.B., and Lorenz R.G. Gastric mucus alterations associated with murine Helicobacter infection. J Histochem Cystochem 57 (2009) 457-467
21. Rokutan K. Role of heat shock proteins in gastric mucosal protection. J Gastroenterol Hepatol 15 (2000) D12-D19
22. Mizushima T. Various stress proteins protect gastric mucosal cells against non-steroidal anti-inflammatory drugs. Inflammopharmacology 15 (2007) 67-73
23. Hiarata T., Naito Y., Handa O., et al. Heat-shock protein 70-overexpressing gastric epithelial cells are resistant to indomethacin-induced apoptosis. Digestion 79 (2009) 243-250
24. Giaraud A.S., Jackson C., Menhenniott T.R., and Judd L.M. Differentiating of the Gastric Mucosa IV. Role of trefoil peptides and IL-6 cytokine family signalling in gastric homeostasis. Am J Physiol Gastrointest Liver Physiol 292 (2007) G1-G5
25. Hernández C., Santamatilde E., McCreath K.J., et al. Induction of trefoil factor (TFF)1, TFF2 and TFF3 by hypoxia is mediated by hypoxia inducible factor-1: implications for gastric mucosal healing. Br J Pharmacol 156 (2009) 262-272
26. Yang Y.H., Wu W.K., Tai E.K., et al. The cationic host defense peptide rCRAMP promotes gastric ulcer healing in rats. J Pharmacol Exp Ther 318 (2006) 547-554
27. Wehkamp J., Schauber J., and Stange E.F. Defensins and cathelicidins in gastrointestinal infections. Curr Opin Gastroenterol 23 (2007) 32-38
28. Tarnawski A. Cellular and molecular mechanisms of mucosal defense and repair. In: Yoshikawa T., and Arakawa T. (Eds). Bioregulation and its disorders in gastrointestinal tract (1998), Blackwell Science, Tokyo, Japan 3-17
29. Niv Y., and Fraser G.M. The alkaline tide phenomenon. J Clin Gastroenterol 35 (2002) 5-8
30. Yao X., and Forte J.G. Cell biology of acid secretion by the parietal cell. Annu Rev Physiol 65 (2003) 103-131
31. Modlin I.M., Kidd M., Lye K.D., et al. Gastric stem cells: an update. Keio J Med 52 (2003) 134-137
32. Tarnawski A., Stachura J., Durbin T., et al. Increased expression of epidermal growth factor receptor during gastric ulcer healing in rats. Gastroenterology 102 (1992) 695-698
33. Hritz I., Herszenyi L., Molnar B., et al. Long-term omeprazole and esomeprazole treatment does not significantly increase gastric epithelial cell proliferation and epithelial growth factor receptor expression and has no effect on apoptosis and p53 expression. World J Gastroenterol 11 (2005) 4721-4726
34. Hritz I., Herszenyi L., Molnar B., et al. Proton pump inhibitor co-therapy normalizes the increased cell turnover of the gastric mucosa both in NSAID and selective COX-2 users. Int J Immunopathol Pahrmacol 18 (2005) 75-84
35. Nguyen T., Chai J., Tanigawa T., et al. Novel roles of local IGF-1 activation in rat gastric ulcer healing: promotes actin polymerization, cell proliferation, re-epithelisation and induces COX-2 in PI3K-dependent manner. Am J Pathol 170 (2007) 1219-1228
36. 2 transactivates EGF receptor: a novel mechanism for promoting colon cancer growth and gastrointestinal hypertrophy. Nat Med 8 (2002) 289-293
37. Chiou S.K., Tanigawa T., Akahoshi T., et al. Survivin: a novel target for indomethacin-induced gastric injury. Gastroenterology 128 (2005) 63-73
38. Jones M.K., Padilla O.R., Webb N.A., and Norng M. The anti-apoptosis protein, survivin, mediates gastric epithelial cell cytoprotection against ethanol-induced injury via activation of the p34(cdc2) cyclin-dependent kinase. J Cell Physiol 215 (2008) 750-764
39. Gannon B., Browning J., O'Brien P., et al. Mucosal microvascular architecture of the fundus and body of the human stomach. Gastroenterology 86 (1984) 866-875
40. Guth P.H. Current concepts in gastric microcirculatory pathophysiology. Yale J Biol Med 65 (1992) 677-688
41. Wallace J.L., and Miller J.S. Nitric oxide in mucosal defense. A little goes a long-way. Gastroenterology 119 (2000) 512-520
42. Brzozowski T., Konturek P.C., Konturek S.J., et al. Role of prostaglandins in gastroprotection and gastric adaptation. J Physiol Pharmacol 56 Suppl. 5 (2005) 33-55
43. Wallace J.L. Nitric oxide, aspirin-triggered lipoxins and NO-aspirin in gastric protection. Inflamm Allergy Drug Targets 5 (2006) 133-137
44. Brzozowski T., Konturek P.C., Pajdo R., et al. Physiological mediators in nonsteroidal anti-inflammatory drugs (NSAIDs)-induced impairment of gastric mucosal defense and adaptation. Focus on nitric oxide and lipoxins. J Physiol Pharmacol 59 Suppl. 2 (2008) 89-102
45. Lanas A. Role of nitric oxide in the gastrointestinal tract. Arthritis Res Ther 10 Suppl. 2 (2008) 1-6
46. Fiorucci S., Antonelli E., Distrutti E., et al. Inhibition of hydrogen sulfide generation contributes to gastric injury caused by anti-inflammatory nonsteroidal drugs. Gastroenterology 129 (2005) 1210-1224
47. Fiorucci S., Distrutti E., Cirino G., and Wallace J.L. The emerging roles of hydrogen sulfide in the gastrointestinal tract and liver. Gastroenterology 131 (2006) 259-271
48. Zanardo R.C., Brancaleone V., Distrutti E., et al. Hydrogen sulfide is an endogenous modulator of leukocyte-mediated inflammation. FASEB J 20 (2006) 2118-2120
49. Takeda M., Hayashi Y., Yamato M., et al. Roles of endogenous prostaglandins and cyclooxygenase izoenzymes in mucosal defense of inflamed rat stomach. J Physiol Pharmacol 55 (2004) 193-205
50. Peskar B.M. Role of cyclooxygenase isoforms in gastric mucosal defense and ulcer healing. Inflammopharmacology 13 (2005) 15-26
51. Konturek S.J., Konturek P.C., and Brzozowski T. Prostaglandins and ulcer healing. J Physiol Pharmacol 56 Suppl. 5 (2005) 5-31
52. Starodub O.T., Demitrack E.S., Baumgartner H.K., and Montrose M.H. Disruption of the Cox-1 gene slows repair of microscopic lesions in the mouse gastric epithelium. Am J Physiol Cell Physiol 294 (2008) C223-C232
53. Holzer B. Neural emergency system in the stomach. Gastroenterology 114 (1998) 823-839
54. Evangelista S. Role of sensory neurons in restitution and healing of gastric ulcers. Curr Pharm Des 12 (2006) 2977-2984
55. Ohno T., Hattori Y., Komine R., et al. Roles of calcitonin gene-related peptide in maintenance of gastric mucosal integrity and in enhancement of ulcer healing and angiogenesis. Gastroenterology 134 (2008) 215-225
56. Szabo S. Mechanisms of gastric mucosal injury and protection. J Clin Gastroenterol 13 (1991) S21-S34
57. Stroff T., Plate S., Respondek M., et al. Protection by gastrin in the rat stomach involves afferent neurons, calcitonin gene-related peptide, and nitric oxide. Gastroenterology 109 (1995) 89-97
58. Mózsik G., Karádi O., Király A., et al. The key-role of vagal nerve and adrenals in the cytoprotection and general gastric mucosal integrity. J Physiol Paris 5 (2001) 229-237
59. 2+ channels. Regul Pept 130 (2005) 81-90
60. Chatzki E., Lambropoulou M., Constandinidis T.C., et al. Corticotropin-releasing factor (CRF) receptor type2 in the human stomach: protective biological role by inhibition of apoptosis. J Cell Physiol 209 (2006) 905-911
61. Gyíres K., Müllner K., and Rónai A.Z. Activation of central opioid receptors may induce gastric mucosal defense in the rat. J Physiol Paris 95 (2001) 189-196
62. Zádori Z., Shujaa N., Köles L., et al. Nocistatin and nociceptin given centrally induce opioid-mediated gastric mucosal protection. Peptides 29 (2008) 2257-2265
63. Brzozowski T., Konturek P.C., Drozdowicz D., et al. Role of central and peripheral ghrelin in the mechanism of gastric mucosal defence. Inflammopharmacology 13 (2005) 45-62
64. De Smet B., Mitselos A., and Depoortere I. Motilin and ghrelin as prokinetic drug targets. Pharmacol Ther 123 (2009) 207-223
65. Ceranowicz P., Warzecha Z., Dembinski A., et al. Treatment with ghrelin accelerates the healing of acetic acid-induced gastric and duodenal ulcers in rats. J Physiol Pharmacol 60 (2009) 87-98
66. Martin G.R., and Wallace J.L. Gastrointestinal inflammation: a central component of mucosal defense and repair. Exp Biol Med 231 (2006) 130-137
67. Rad R., Dossumbekova A., Neu B., et al. Cytokine gene polymorphisms influence mucosal cytokine expression, gastric inflammation, and host specific colonisation during Helicobacter pylori infection. Gut 53 (2004) 1082-1089
68. Kossoulas V., Vassiliou S., Giamarellos-Bourboulis E.J., et al. Implications for a role of interleukin-23 in the pathogenesis of chronic gastritis and of peptic ulcer disease. Clin Exp Immunol 156 (2009) 97-101
69. Bartchewsky W., Martini M.R., Masiero M., et al. Effect of Helicobacter pylori infection on IL-8, IL-1beta and COX-2 expression in patients with chronic gastritis and gastric cancer. Scand J Gastroenterol 44 (2009) 153-161
70. Playford R.J., and Ghosh S. Cytokines and growth factor modulators in intestinal inflammation and repair. J Pathol 250 (2005) 417-425
71. Luo J.C., Shin V.Y., Wu W.K., et al. Tumor necrosis factor-alpha stimulates gastric epithelial cell proliferation. Am J Physiol Gastrointest Liver Physiol 288 (2005) G32-G38
72. Kosone T., Takagi H., Kakizaki S., et al. Integrative roles of transforming growth factor-alpha in the cytoprotection mechanisms of gastric mucosal injury. BMC Gastroenterol 6 22 (2006) 10.1186/1471-230X-6-22
73. Herszenyi L., Plebani M., Carraro P., et al. Impaired fibrinolysis and increased protease levels in gastric and duodenal mucosa of patients with active duodenal ulcer. Am J Gastroenterol 92 (1997) 843-847
74. Tomita M., Ando T., Minami M., et al. Potential role of matrix metalloproteinase-3 in gastric ulcer healing. Digestion 79 (2009) 23-29
75. Judd L.M., Ulaganathan M., Howlett M., and Giraud A.S. Cytokine signalling by gp130 regulates mucosal healing after ulceration and, indirectly, antral tumour progression. J Pathol 21 (2009) 552-562
76. Hritz I., Kuester D., Herszenyi L., et al. Secretory leucocyte protease inhibitor expression in various types of gastritis: a specific role of Helicobacter pylori infection. Eur J Gastroenterol Hepatol 18 (2006) 277-282
77. Johnson L.R., and McCormack S.A. Healing of gastrointestinal mucosa: involvement of polyamines. News Physiol Sci 14 (1999) 12-17
78. Thomas T., and Thomas T.J. Polyamines in cell growth and cell death: molecular mechanisms and therapeutic applications. Cell Mol Life Sci 58 (2001) 244-258
79. Pegg A.E. Regulation of ornithine decarboxylase. J Biol Chem 281 (2006) 14529-14532
80. Cheng Y., Chatervudi R., Asim M., et al. Helicobacter pylori-induced macrophage apoptosis requires actviation of ornithine decarboxylase by c-Myc. J Biol Chem 280 (2005) 22492-22496
81. Kawabata A., Nishikawa H., Saitoh H., et al. A protective role of protease-activated receptor 1 in rat gastric mucosa. Gastroenterology 126 (2004) 208-219
82. Ma L., Perini R., McKnight W., et al. Proteinase-activated receptors 1 and 4 counter-regulate endostatin and VEGF release from platelets. Proc Natl Acad Sci U S A 102 (2005) 216-220
83. Kawabata A., Matsunami M., and Sekiguchi F. Gastrointestinal roles of proteinase-activated receptors in health and disease. Br J Pharmacol 153 Suppl. 1 (2008) S230-S240
84. Yoshida N., and Yoshikawa T. Basic and translational research on proteinase-activated receptors: implications of proteinase/proteinase-activated receptors in gastrointestinal inflammation. J Pharmacol Sci 108 (2008) 415-421
85. Tarnawski A.S. Cellular and molecular mechanisms of gastrointestinal ulcer healing. Dig Dis 50 Suppl. 1 (2005) S24-S33
86. Wallace J.L., Dicay M., McKnight W., and Dudar G.K. Platelets accelerate gastric ulcer healing through presentation of vascular endothelial growth factor. Br J Pharmacol 148 (2006) 274-278
87. Tarnawski A., Stachura J., Ivey K.J., et al. Ethanol-induced duodenal lesions in man. Protective effect of prostaglandin. Prostaglandins 21 Suppl. (1981) 147-153
88. Terano A., Ota S., Mach T., et al. Prostaglandin protects against taurocholate-induced damage to rat gastric mucosal cell culture. Gastroenterology 92 (1987) 669-677
89. Halter F., Tarnawski A.S., Schmassmann A., and Peskar B.M. Cyclooxygenase 2-implications on maintenance of gastric mucosal integrity and ulcer healing: controversial issues and perspectives. Gut 49 (2001) 443-453
90. Szabo S., Nagy L., and Plebani M. Glutathione, protein sulfhydryls and cysteine proteases in gastric mucosal injury and protection. Clin Chim Acta 206 (1992) 95-105
91. Wallace J.L. Hydrogen sulphide-releasing anti-inflammatory drugs. Trends Pharmacol Sci 28 (2007) 501-505
92. Slomiany B.L., and Slomiany A. Leptin-induced cytosolic phospholipase A2 activation in gastric mucosal protection against ethanol cytotoxicity involves epidermal growth factor receptor transactivation. Inflammopharmacology 17 (2009) 6-14
93. Arakawa T., Higuchi K., Fujiwara Y., et al. Fifteenth anniversary of rebamipide: looking ahead to the new mechanisms and new applications. Dig Dis Sci 50 Suppl. 1 (2005) S3-S11
94. Iijima K., Ichikawa T., Okada T., et al. Rebamipide, a cytoprotective drug, increases gastric mucus secretion in human: evaluations with endoscopic gastrin test. Dig Dis Sci 54 (2009) 1500-15007
95. Tarnawski A., Tomikawa A., Ohta M., et al. Antacid talcid activates in gastric mucosa genes encoding for EGF and its receptor. The molecular basis for its ulcer healing action. J Physiol (Paris) 94 (2000) 93-98
96. Szabo S., Khomenko K., Gombos Z., et al. Review article: transcription factors and growth factors in ulcer healing. Aliment Pharmacol Ther 14 Suppl. 1 (2000) 33-43
97. Mizuki A., Tatemichi M., Nishiya H., et al. Mucosal concentrations of basic fibroblast growth factor in the healing process in human giant gastric ulcers. J Gastroenterol Hepatol 19 (2004) 528-534
98. Quenot J.P., Thiery N., and Barbar S. When should stress ulcer prophylaxis be used in the ICU. Curr Opin Crit Care 15 (2009) 139-143